Keyword

Ewing sarcoma

Description: Ewing sarcoma is an aggressive cancer that usually arises in bone or soft tissue, studied in oncology, pathology, and cancer treatment.

Primary topic: Sarcoma Diagnosis and Treatment (65%)

Wikidata ID: wiki/Q1138580

OpenAlex ID: keywords/ewing-sarcoma

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

2012 · Jordi Barretina, Giordano Caponigro, et al. · Nature · 7,929

Systematic identification of genomic markers of drug sensitivity in cancer cells

2012 · Mathew J. Garnett, Elena J. Edelman, et al. · Nature · 2,453

Pathology and genetics of tumours of soft tissue and bone

2002 · Christopher D.�M. Fletcher, K. Krishnan Unni, et al. · Medical Entomology and Zoology · 2,069

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

1992 · Olivier Delattre, Jessica Zucman, et al. · Nature · 1,903

The Epidemiology of Osteosarcoma

2009 · Giulia Ottaviani, Norman Jaffe · Cancer treatment and research · 1,797

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 · Holcombe E. Grier, Mark D. Krailo, et al. · New England Journal of Medicine · 1,329

The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives

2020 · Marta Sbaraglia, Elena Bellan, et al. · Pathologica · 1,139

PDF

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

1994 · Olivier Delattre, Jessica Zucman, et al. · New England Journal of Medicine · 1,108

PDF

Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group

2000 · S.J. Cotterill, S. Ahrens, et al. · Journal of Clinical Oncology · 1,040

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

2015 · Nabil Ahmed, Vita S. Brawley, et al. · Journal of Clinical Oncology · 1,003

Chordoma: incidence and survival patterns in the United States, 1973–1995

2001 · Mary L. McMaster, Alisa M. Goldstein, et al. · Cancer Causes & Control · 966

Ewing sarcoma

2018 · Thomas G. P. Grünewald, Florencia Cidre-Aranaz, et al. · Nature Reviews Disease Primers · 869

The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

2022 · Holger Moch, Mahul B. Amin, et al. · European Urology · 846

PDF

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

2012 · Richard B. Womer, Daniel C. West, et al. · Journal of Clinical Oncology · 760

PDF

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG

1994 · Poul H.B. Sorensen, Stephen L. Lessnick, et al. · Nature Genetics · 748

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

2015 · Nathalie Gaspar, Douglas S. Hawkins, et al. · Journal of Clinical Oncology · 724

Ewing's sarcoma

2010 · Naomi J Balamuth, Richard B Womer · The Lancet Oncology · 706

Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study

2010 · Debra L. Friedman, John Whitton, et al. · JNCI Journal of the National Cancer Institute · 703

PDF

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

2019 · Robbie G. Majzner, Johanna L. Theruvath, et al. · Clinical Cancer Research · 678

The Epidemiology of Sarcoma

2012 · Zachary Burningham, Mia Hashibe, et al. · Clinical Sarcoma Research · 664

PDF

Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients

2012 · ONDREJ ZITKA, SYLVIE SKALICKOVA, et al. · Oncology Letters · 663

PDF

Common Musculoskeletal Tumors of Childhood and Adolescence

1999 · Carola A.S. Arndt, William M. Crist · New England Journal of Medicine · 662

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration

1991 · Inge M. Ambros, Peter F. Ambros, et al. · Cancer · 657

PDF

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

2018 · P.G. Casali, S. Bielack, et al. · Annals of Oncology · 616

PDF

Soft tissue sarcomas of adults: state of the translational science.

2003 · Ernest C Borden, Laurence H Baker, et al. · PubMed · 614

Works count: 21,150

Citation count: 331,400